Objective: To determine whether supplementation with vitamin B 6 improves nausea and/or vomiting in pregnancy. Methods: This experimental study was conducted with 60 pregnant women experiencing nausea and/or vomiting prior to the 12th gestational week. Of these women, 30 were treated daily with 10 mg and the remaining 30 with 1.28 mg of pyridoxine hydrochloride for 2 weeks. The primary outcome was the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score in each group at the end of treatment. Results: The women experiencing nausea and/or vomiting in pregnancy had significantly lower levels of circulating vitamin B 6 (P = 0.007) compared with those without this symptom. Vitamin B 6 supplementation significantly increased plasma vitamin B 6 concentration (P < 0.05 in both groups). There were no significant differences in PUQE score or in plasma concentration levels of protein, dopamine, serotonin, unconjugated estriol, and ghrelin after supplementation between the 2 groups at baseline, but there was a significantly lesser decrease in PUQE score and a greater increase in vitamin B 6 level and vitamin B 6 concentration to plasma protein concentration ratios in group 1 than in group 2 after supplementation (P < 0.05 for all). Conclusion: Although the high-supplementation group had a greater decrease in PUQE score in comparison to the low-supplementation group, the difference is unlikely to affect the severity of symptoms. © 2011 International Federation of Gynecology and Obstetrics.
Wibowo N, Purwosunu Y, Sekizawa A, Farina A, Tambunan V, Bardosono S. (2012). Vitamin B6 supplementation in pregnant women with nausea and vomiting. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 116, 206-210 [10.1016/j.ijgo.2011.09.030].
Vitamin B6 supplementation in pregnant women with nausea and vomiting.
FARINA, ANTONIO;
2012
Abstract
Objective: To determine whether supplementation with vitamin B 6 improves nausea and/or vomiting in pregnancy. Methods: This experimental study was conducted with 60 pregnant women experiencing nausea and/or vomiting prior to the 12th gestational week. Of these women, 30 were treated daily with 10 mg and the remaining 30 with 1.28 mg of pyridoxine hydrochloride for 2 weeks. The primary outcome was the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score in each group at the end of treatment. Results: The women experiencing nausea and/or vomiting in pregnancy had significantly lower levels of circulating vitamin B 6 (P = 0.007) compared with those without this symptom. Vitamin B 6 supplementation significantly increased plasma vitamin B 6 concentration (P < 0.05 in both groups). There were no significant differences in PUQE score or in plasma concentration levels of protein, dopamine, serotonin, unconjugated estriol, and ghrelin after supplementation between the 2 groups at baseline, but there was a significantly lesser decrease in PUQE score and a greater increase in vitamin B 6 level and vitamin B 6 concentration to plasma protein concentration ratios in group 1 than in group 2 after supplementation (P < 0.05 for all). Conclusion: Although the high-supplementation group had a greater decrease in PUQE score in comparison to the low-supplementation group, the difference is unlikely to affect the severity of symptoms. © 2011 International Federation of Gynecology and Obstetrics.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.